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1.1 The Thyroid 
CHAPTER 1 
INTRODUCTION 
The thyroid is a bilobed organ located in the neck and is the largest organ that functions 
exclusively as an endocrine gland (Capen, 2000). The two lobes of the thyroid are 
connected by the isthmus which lies over the trachea. The basic structure of the thyroid 
consists of many, different sized, follicles that are filled with colloid produced by 
follicular cells (Capen, 2000). These cells contain rough endoplasmic reticulum (ER) and 
a large Golgi apparatus in the cytoplasm, structures important for the synthesis of the 
thyroid proteins thyroglobulin {Tg) and thyroid peroxidase {TPO) (Capen, 2000). The 
main function of the thyroid is to produce and secrete the thyroid hormones, thyroxine 
{T4) and triiodothyronine {T3) (Dunn & Dunn, 2001), which are important for regulating 
metabolic processes in the body. These processes include growth, development, oxygen 
consumption, and protein, lipid, carbohydrate and vitamin metabolism (Yen, 2005). 
1.1.1 Thyroid Stimulating Hormone (TSH) and thyroid regulation 
The process of hormone synthesis and secretion in the thyroid is regulated by thyroid 
stimulating hormone (TSH) or thyrotrophin, a glycoprotein produced by the pituitary 
gland. This protein binds to its TSH receptor {TSHR), which is found mainly on the 
surface of thyroid follicular cells (Santisteban, 2005). Binding ofTSH to its TSHR 
increases the endocytosis of thyroglobulin (Tg), leading to increased synthesis and 
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secretion of thyroid hormone, as well as the differentiation and proliferation of the thyroid 
(Santisteban, 2005). Further, the production ofTSH is under the control of thyrotrophin-
releasing hormone (TRH) which is secreted by the hypothalamus and acts on the anterior 
pituitary gland. A negative feedback loop is the key to the regulation of hormone 
synthesis and secretion. 
1.2 Hashimoto's thyroiditis (HT) 
Autoimmune thyroid disease (AITD) specifically targets the thyroid and is characterized 
by lymphocytic infiltration of the gland as well as the production of thyroid 
autoantibodies (autoAb) in the serum (Weetman, 2004). AITD is not a disease itself, but 
a collection of diseases. Two clinically significant AITD diseases are Graves' disease 
(GD) which affects - 1% of women (Weetman, 2000) and Hashimoto's thyroiditis (HT) 
which affects 1-2% of women (Pearce et al. , 2003). HT or chronic lymphocytic 
thyroiditis (CLT) is the most common AITD in humans (Pearce eta/., 2003). 
HT or struma lymphomatosa was first described by the Japanese surgeon, Hakaru 
Hashimoto in 1912 (Hashimoto, 1912; Aozasa, 1990). This disease affects mainly middle 
aged women at an 8:1 to 9:1 female to male ratio (Pearce eta/. , 2003). In HT, once 
thyroid antigen-specific helper T cells become activated the anti-thyroid immune 
response begins. The activated helper T cells cause: 1) B cells to secrete autoAb against 
thyroid autoantigens and 2) cytotoxic T cells to become activated to home to, infiltrate, 
and destroy the thyroid gland. However, the mechanisms involved in the initial activation 
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of these helper T cells are still unknown (Pearce et al., 2003). It has been reported that 
thyrocytes from patients with HT express the Fas gene, whereas thyrocytes from patients 
without HT do not (Pearce eta!., 2003). Furthermore, CD4+ killer T cells express Fas 
Ligand (FasL) which is able to bind to thyrocytes from patients with HT and cause FasL-
medicated apoptosis (Pearce et al., 2003). The gradual destruction of the thyroid gland 
by lymphocytic infiltration, the production of autoAb in the serum which are specific for 
the thyroid autoantigens, Tg (Roitt I.M et al., 1956) and TPO (Weetman & McGregor, 
1994), and formation of goiter (Pearce et al., 2003) are all characteristics of HT. It has 
been shown that susceptibility to HT is under the control of both genetic (human 
leukocyte antigen (HLA-DR) alleles, cytotoxic T lymphocyte antigen (CTLA)-4 
polymorphisms, and thyroid specific genes, like Tg) and environmental (iodine intake) 
factors (Ban & Tomer, 2005; Weetman, 2004). Tg has also been found to play a role in 
the susceptibility of thyroiditis. Ban and Tomer studied the Tg gene which is located on 
chromosome 8q24 and found that there were susceptibility genes linking to AITD (Ban & 
Tomer, 2005). From this gene they identified two new Tg microsatellites in intron 10 
(Tgmsl) and intron 27 (Tgms2) which through familial studies showed that only Tgrns2 
was linked and associated with AITD, making it a an important AITD susceptibility gene 
(Ban & Tomer, 2005). It has also been documented that HT is the leading cause of 
hypothyroidism and goiter in humans who live in countries where dietary iodine intake is 
sufficient (Pearce et al., 2003). 
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1.2.1 Hypothyroidism in HT 
The development of hypothyroidism in patients with HT is a consequence of depleted 
circulating honnone levels. These hormones become depleted as a result of decreasing 
production and secretion ofT4 and T3 by the thyroid (Braverman and Utiger, 2005). This 
may occur due to destruction of the thyroid gland by mononuclear cell infiltration. 
As the function of the thyroid gland begins to fail, a person with HT will develop 
subclinical hypothyroidism, showing normal hormone levels and elevated TSH 
concentrations in their serum. As the disease progresses and thyroid function fails, TSH 
concentrations become elevated (normal range 0.4-4.0 mlU/L; Hurd, 2007) and T4 
concentrations decrease in the serum. Normal T 4 levels are between 5-13.5 11g/dL (Evans, 
2005). This stage of hypothyroidism is called overt hypothyroidism. The T3 levels 
(normal range 1.2-3.4 nmol/L) in the serum usually drop sometime after the T4 levels, 
however, once the T 3 level drops, a patient will experience the classical signs of HT 
(Pearce et al., 2003) such as goiter, constant fatigue, poor memory, constipation, etc. 
(Ginsberg et al., 2007). 
1.3 Experimental autoimmune thyroiditis (EAT) 
Experimental autoimmune thyroiditis (EAT) is the animal model of HT. There are many 
animal models which have been used to study EAT, such as the rabbit (Rose & Witebsky, 
1956), the mouse (Rose et al., 1971), the guinea-pig, the dog (Terplan et al., 1960), the rat 
(Jones and Roitt, 1961 ), the chicken (Jankovic, 1965), and the rhesus monkey (Rose et 
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al., 1966). These models are Tg-induced EAT models, but they are considered ideal in 
the study of HT because they show similarities in development of the disease. This is 
evident in the destruction of the thyroid gland by mononuclear cell infiltration and the 
production of autoantibodies ( autoAb) to Tg in the serum. 
1.3.1 Thyroglobulin-induced EAT in the mouse 
In order to study EAT in animals which do not develop the disease spontaneously, disease 
must be induced either directly or indirectly. Direct induction of EAT requires animals to 
be challenged with a thyroid antigen in adjuvant. This method has been used since 1956, 
when Rose and Witebsky first immunized rabbits subcutaneously (s.c.) with homologous 
thyroid tissue in complete Freund's adjuvant (CF A) (Rose and Witebsky, 1956). They 
discovered that rabbits who received these injections showed lymphocytic infiltration in 
their thyroid glands and produced thyroid autoAb in their serum. Since 1956, many 
methods have been used to induce EAT in the mouse. They include challenge with 
mouse thyroglobulin (mTg) in different types of adjuvants such as lipopolysaccharide 
(LPS) and CFA (Esquivel et al., 1977), mTg conjugated to monoclonal antibodies instead 
of adjuvants (Balasa & Carayanniotis, 1993), and repeated injections oflarge amounts of 
Tg in small doses in the absence of adjuvant (Elrehewy et al. , 1981 ). All these methods 
were successful in eliciting IgG production to mTg. However, not all methods caused 
mononuclear cell infiltration in the thyroid gland (Balasa & Carayanniotis, 1993). The 
most commonly used technique for inducing EAT in mice is through s.c. injection with 
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homologous Tg in CFA followed by a booster injection ofTg in incomplete Freund's 
adjuvant (IF A) 2-3 weeks later (Charreire, 1989; Weetman & McGregor, 1984; Weetman 
& McGregor, 1994). This method successfully leads to the induction ofEAT whereby 
antibodies (Ab) to mTg are produced in the serum and extensive infiltration is detected in 
the thyroid gland. 
EAT can also be indirectly induced by adoptive transfer of lymph node or spleen cells 
from animals immunized with Tg in CF A into na1·ve syngeneic recipients. EAT appears 
2-3 weeks post-transfer and is evident by mononuclear cell infiltration in the gland and 
the production of Ab to Tg in the serum (Braley-Mullen et al., 1985). Another method 
used to indirectly induce EAT is thymectomy with repeated sub-lethal irradiation. This 
procedure may be performed in animals immediately after birth or later in life. One study 
showed that 60% of the thymectomized Wistar rats which received whole body 
irradiation developed EAT spontaneously, 60 days after the last irradiation compared to 
0% of the untreated control rats (Penhale et a/., 1973). It has been hypothesized that this 
method selectively depletes T cells responsible for suppressing EAT (Penhale et al., 
1976). With the depletion of this population, there is a loss of tolerance to self-thyroid 
antigens and the development of EAT (Penhale et al., 1976). A second study showed that 
the putative suppressor cells were of thymic origin and that reconstituting thymectomized 
rats with normal lymphoid or spleen cells during the development of disease could 
suppress EAT (Penh ale et al., 1976). Even under optimal conditions, only certain strains 
of mice are susceptible to Tg-induced EAT. This susceptibility is under the genetic 
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control of the major histocompatibility (MHC) gene, H2. A study by Vladutiu and Rose 
showed that there are good and poor responder mouse strains in Tg-induced EAT 
(Vladutiu & Rose, 1971). They immunized 33 inbred strains of mice representing 11 H2 
types, twice (7 -day intervals) with thyroid extract emulsified in CF A. They discovered 
that there were differences in immune responses in mice with different H2 haplotypes 
(Vladutiu & Rose, 1971 ). Mice which are HZ or H2k are considered good responder 
strains because they produce high titers of Ab to mTg and show extensive mononuclear 
cell infiltration in their thyroids. On the other hand, mice which are H2d and H2b are poor 
responder strains because they produce very low levels of Ab to mTg in their serum and 
show little if any infiltration in their thyroid glands after immunization with thyroid 
extracts in CF A (Vladutiu & Rose, 1971 ). 
1.3.2 Spontaneous autoimmune thyroiditis (SAT) 
Spontaneous autoimmune thyroiditis (SAT) can develop in many animal models, such as 
Obese strain (OS) chickens (Witebsky et al. , 1969), Buffalo (BUF) rats (Hajdu & Rona, 
1969), and non obese diabetic NOD.H2h4 mice (Rasooly et al. , 1996). In NOD.H2h4 
mice, SAT is characterized by the destruction of the thyroid gland by mononuclear cell 
infiltration and the production of the Tg autoantibodies, lgGl and lgG2b (Braley-Mullen 
et al., 1999; Rasooly et al., 1996) which is similar to HT. The cells mainly involved in 
the destruction of the thyroid gland are comprised of CD4+ and CD8+ T cells, and B220+ 
cells (Yu et al. , 2006). It has been documented that the production oflgG1 and IgG2b Ab 
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correlate with SAT severity scores (Braley-Mullen et al., 1999). However, it has also 
been documented that the production oflgG2b only, correlated with SAT severity 
(Rasooly et al., 1996). 
1.3.2.1 SAT in NOD.H2h4 mice 
The NOD.H2h4 mouse strain was developed during a study which tested the role of I-E 
MHC expression on the development of insulitis and diabetes in mice with the NOD 
background (Podolin et al., 1993). NOD.H2h4 mice were derived by crossing NOD(H2g7) 
mice (which spontaneously develop type I diabetes (Kikutani & Makino, 1992) and have 
a low incidence of thyroiditis (Damotte et al., 1997), as seen in histological examinations 
ofNOD pancreata and thyroids) with B10.A(4R)(H2h4) mice (which express theAk allele 
making them susceptible to thyroiditis (Vladutiu & Rose, 1971 )). The heterozygous 
progeny from the first generation, expressing the Ak gene were repeatedly backcrossed 
with NOD mice until the sixth generation, in which brother-sister matings (H2h41h4) 
occurred (Podolin et al., 1993). The resulting NOD.H2h4 mice produced are E and 
express A\ K", and Db on the NOD background (Podolin et al., 1993). These mice 
develop SAT (Rasooly et al., 1996), some insulitis, but no diabetes (Podolin et al. , 1993; 
Weatherall et a!., 1992) compared to their parental strain. 
According to Braley-Mullen et al., untreated NOD.H2h4 mice do not develop SAT before 
the age of 6 months (Braley-Mullen et al., 1999). However, studies have shown that 
supplementing 0.05% sodium iodide (0.05% Nal) in the drinking water of 6-8 week old 
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NOD.H2h4 mice, for 8 weeks, accelerates the onset and increases the severity of SAT in 
the thyroid, as well as the production ofTg Ab (mostly IgG2b and some IgGl) in the 
serum (Braley-Mullen et al., 1999; Rasooly et al., 1996). Also, Rasooly et al. showed 
that the addition ofNal in the drinking water ofNOD.H2h4 mice had no affect on serum 
thyroxine levels and antibodies to TPO could not be detected in both iodine-treated and 
control mice (Rasooly et al. , 1996). 
Studies have shown that CD4+ and CD8+ T cells are essential for SAT development 
(Braley-Mullen et al., 1999; Hutchings et al., 1999). Depletion ofCD4+ or CD8+ T cells 
in NOD.H2h4 mice before SAT development minimized or prevented SAT and decreased 
anti-mTg autoAb in the serum. However, in mice which had already developed SAT, 
they found that only CD4+ T cell depletion could minimize or prevent SAT development. 
Also, they found that CD4+ T cell depletion only slightly reduced anti-mTg autoAb levels 
in the serum compared to control mice who had their CD4+ T cells intact (Braley-Mullen 
et al., 1999). The depletion ofboth CD4+ and CD8+ T cells in NOD.H2h4 mice showed 
similar results as those only having CD4+ T cells depleted. Therefore, CD4+ T cells are 
essential in the initial development and maintenance of SAT and CD8+ T cells are only 
essential in the initial development of SAT in NOD.H2h4 mice (Braley-Mullen eta!. , 
1999). 
The kinetics of SAT in NOD.H2h4 mice has also been studied. Braley-Mullen et al. 
reported that mice given 0.05% Nal water for 2 weeks showed lesions in their thyroids 
(Braley-Mullen et al., 1999). Also, NOD.H2h4 mice on Nal water for 8 weeks showed 
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maximum SAT severity in their glands with severity of disease persisting for an 
additional 15 weeks (23 weeks on Nal water). Braley-Mullen et al. noticed that males 
appeared to have more severe lesion development than females. However, this was not 
statistically significant (Braley-Mullen et al., 1999) and this was confirmed by another 
study (Rasooly et al., 1996). The cells found infiltrating the thyroids of these mice were 
mainly CD4+ T cells, then B cells, and then CD8+ T cells (Yu et al. , 2001). It is important 
to note that SAT development also requires the presence of B cells early in life in 
NOD.H2h4 mice. Braley-Mullen et al. reported that the absence ofB cells in NOD.H2h4 
mice leads to minimal or no SAT development (Braley-Mullen & Yu, 2000). This is 
because B cells are required early in life when T cells are maturing. Reconstituting B cell-
depleted NOD.H2h4 mice with B cells only elevated antibody levels but had no effect on 
SAT development. However, ifB cell-deficient NOD.H2h4 mice were irradiated and then 
given bone marrow from B cell-deficient mice and B cells from normal mice, thyroiditis 
occurred. Therefore, T cells from B cell-deficient NOD.H2h4 mice are capable of 
destroying the thyroid if they mature in the presence ofB cells (Braley-Mullen & Yu, 
2000). The lack of SAT development in B cell-deficient NOD.H2114 mice may be due to 
the lack of B cells activating autoreactive T cells. An experiment conducted by Yu et al. 
reported that regulatory T cells (Tregs) may play a role in the resistance to SAT 
development in B cell-deficient mice (Yu et al. , 2006). They reported that B cell-
deficient mice have similar levels ofT regs in their spleens and peripheral blood as 
wildtype (NOD.H2h4) mice. However, B cell-deficient mice do not develop SAT. 
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Therefore, this lack of SAT development is not due to elevated Tregs levels in B cell-
deficient mice. B cell-deficient mice without Tregs developed SAT, revealing that the 
presence ofT regs has some role in SAT resistance in B cell-deficient mice. Maybe Tregs 
are important in inhibiting the activation of autoreactive T cells required for SAT 
development in these mice (Yu et al., 2006). 
1.4 Thyroglobulin 
1.4.1 Biosynthesis of Tg 
Tg, the major autoantigen in autoimmune thyroiditis, is a large homodimeric glycoprotein 
weighing - 660 kDa (Dunn & Dunn, 2000). Tg is produced, stored, and secreted from the 
follicular lumen of the thyroid follicles. The production ofTg is physiologically 
controlled by the pituitary glycoprotein TSH (Dunn & Dunn, 2000) and its main purpose 
is to provide a matrix for the synthesis of the thyroid hormones T3 and T4. Before Tg can 
aid in the synthesis of these hormones, a series of posttranslational modifications have to 
occur. Firstly, the unfolded immature Tg molecule must enter the endoplasmic reticulum 
(ER) where it is folded into a stable dimer. This process is facilitated by enzymes 
(protein disulfide isomerase and peptydylprolyl isomerase) and molecular chaperones 
(calnexin, BiP, GRP94, and Erp72) (Dunn & Dunn, 2000). The molecular chaperones 
also play a role in preventing improperly folded or premature Tg from leaving the ER. 
Once Tg is properly folded, it is allowed to migrate from the ER to the Golgi complex 
where it completes the processing of its carbohydrate units through the addition of sugars, 
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sulfates, and phosphates. The mature Tg molecule is now ready to be transported from 
the Golgi to the apical cell surface in apical vesicles. Here at the apical cell surface, the 
mature Tg molecule is iodinated (Dunn & Dunn, 2000). To date, the complete sequences 
of human thyroglobulin (hTg) (Malthiery & Lissitzky, 1987), bovine thyroglobulin (bTg) 
(Mercken eta/. , 1985) and mTg (Caturegli eta/. , 1997) have been documented. The 
mature sequences for each are as follows: hTg contains 2748 amino acids (a.a.), bTg 
contains 2750 a.a and mTg contains 2748 a.a (Caturegli et al. , 1997; Malthiery & 
Lissitzky, 1987; Mercken et al. , 1985). It has also been shown that mTg is 71.8 % and 
73 .5% homologous to hTg and bTg, respectively 
1.4.2 Iodine in Tg 
In vertebrates, the thyroid is the only tissue in the body capable of concentrating iodide 
(I} Tg incorporates and stores available iodine (h) in the form of iodotyrosyls, such as 
mono-iodotyrosine (MIT) and di-iodotyrosine (DIT). Intramolecular coupling of two 
iodotyrosyls, either two DIT or one MIT and one DIT, form the thyroid hormones T4 and 
T 3, respectively (Dunn, 1995). There are four major hormonogenic sites in each 
monomer ofTg (Dunn & Dunn, 2000). In order for Tg to become iodinated, both mature 
Tg and reactive h must be present on the apical cell surface of the thyrocyte. The 
formation of reactive h is formed by the uptake of r from the circulation by the sodium 
iodide (Na+/r) symporter (NIS), a plasma membrane protein (Levy eta/. , 1997). The NIS 
is present on the basolateral membrane of the thyrocyte and aids in the transport of r 
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across the thyroidal cell membrane along an electrochemical gradient to the apical cell 
surface. This process is made possible by the Na+ ion gradient which is the driving force 
for r uptake and is maintained by the sodium/potassium (Na +;K+)-ATPase (Capen, 2000). 
The inward flow ofNa+ ions into the thyrocyte simultaneously allows the inward flow of 
r ions into the thyrocyte (Levy et al., 1997). Once r is transported to the follicular 
lumen, enzymes such as TPO and hydrogen peroxide, oxidize r to reactive h which can 
now bind to tyrosyl residues within Tg (Levy et al. , 1997). Once Tg becomes iodinated, 
the thyroid hormones, mediated by TPO, can be fonned (Dunn & Dunn, 2001). In order 
for T3 and T4 to be released into the circulation, they need to be cleaved from iodinated 
Tg. This is accomplished through the endocytosis ofTg in the form of colloid droplets. 
These droplets then fuse with lysosomes containing proteolytic enzymes which hydrolyze 
Tg and remove T3 and T4 from the Tg backbone (Santisteban, 2005). 
1.4.3 Epitope mapping of Tg 
Numerous methods have been used to screen Tg for antigenic T -cell determinants. Two 
of these methods have used T cell hybridoma clones specific for mTg and computerized 
algorithms. The first T cell epitope discovered was a 9mer Tg peptide (2551-59) which 
contained T4 at position 2553. The 40 mer hTg peptide (1672-1711) was found as a 
result of an experiment using a cytotoxic T cell hybridoma and tryptic fragments from 
porcine thyroglobulin (pTg) (Texier et al., 1992). Synthesis of a 40-amino acid peptide 
13 
similar to a portion ofhTg was tested and shown to induce lymphocytic infiltration in the 
thyroid glands of CBA/J mice (Texier et al., 1992). 
Computerized algorithms designed to predict T cell epitopes in a protein sequence 
(Altuvia et al, 1994; Margalit eta/., 1987; Rothbard & Taylor, 1988) have been used in 
our laboratory to search for A k -restricted, EAT -causing, T cell epitopes in Tg 
(Carayanniotis, eta/., 1994; Chronopoulou & Carayanniotis, 1992; Rao et al. , 1994; Rao 
& Carayanniotis, 1997; Verginis et al., 2002). Many mTg epitopes have been identified 
because they contain a.a. sequence motifs indicating putative binding A k' Ek and A5 
molecules. Extensive use has been made of an algorithm developed by Altuvia eta/. that 
searches for A k and Ek -binding motifs based on size, hydrophobicity, etc. important for 
peptide binding to A k and Ek molecules (Altuvia et al. , 1994 ). To date, the use of 
computerized algorithms and hybridomas has led to the discovery of 23 Tg peptides 
(Carayanniotis, 2007), four of which contain hormonogenic sites (Carayanniotis, 2003), 
four which contain iodotyrosyl residues (Li & Carayanniotis, 2006), and 15 which do not 
contain iodine (Carayanniotis, 2007). Using the algorithm described by Altuvia et al. , Li 
& Carayanniotis (2006) scanned the complete murine Tg sequence for the presence of A k_ 
binding motifs flanked by tyrosine residues to determine if iodotyrosyls alter the 
immunogenicity ofTg peptides (Li & Carayanniotis, 2006). A total of20 sites were 
discovered and 13 Tg peptides and their iodinated analogues were synthesized. CBA/J 
mice were challenged with each Tg peptide and nine days later draining lymph nodes 
were collected and the cells were cultured in the presence of their respective peptides. 
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The results showed that the addition of iodotyrosyl residues had a variety of effects on the 
immunogenicity of the 13 Tg peptides. For seven of the 13 Tg peptides tested, the 
iodination status had no effect on the immunogenicity. However, for the Tg peptides 
p179, p2540, & p2529 which were immunogenic in their non-iodinated form there were 
variable effects in their iodinated form. They found that the addition of iodine to each of 
these Tg peptide sequences caused an increase, decrease, or did not alter the 
immunogenic profile of these Tg peptides, respectively. Further, they found that for the 
Tg peptides p 117, p304, & p 1931 which were non-immunogenic in non-iodinated form, 
the addition of iodotyrosyl residues increased the immunogenicity of these Tg peptides 
(Li & Carayanniotis, 2006). 
1.4.4. Dominance and crypticity 
To date, none of the Tg peptides tested have been found to be immunodominant. An 
epitope is considered dominant when it can be detected by T cells following processing of 
intact Ag in vivo and in vitro (Sercarz et al., 1993). Although immunodominant epitopes 
have not been discovered in Tg, seven Tg peptides have been found to be subdominant 
(Jiang et al. , 2007). An epitope is subdominant when peptide-primed T cells irregularly 
respond to intact antigen (Ag) in vivo and/or in vitro. It is also important to note that in 
order to detect a subdominant epitope, the molar concentrations of intact Ag have to be 
much higher than those required by free peptide (Jiang et al., 2007). To determine if an 
epitope is dominant or cryptic, proliferation assays are conducted after disease is induced 
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by a protein Ag (Moudgil & Sercarz, 2005). A dominant epitope is more readily 
available to, and has a higher affinity for binding to, MHC molecules (Sercarz, 2002) 
compared to cryptic epitopes. There are three reasons why some determinants are cryptic. 
One reason is processing; improper processing of a molecule can render a previously 
cryptic epitope dominant (Moudgil & Sercarz, 2005). Another reason is competition. 
Competition can lead to I) the generation of cryptic epitopes by reducing the number of 
MHC class II binding sites and/or 2) multiple MHC molecules may bind to different 
determinants on the same molecule in which the dominant epitope will be presented 
(Moudgil & Sercarz, 2005). A final reason for the crypticity of an epitope is hindrance; T 
cell receptor {TCR) access to the MHC-peptide complex can be blocked by flanking 
amino acid residues inhibiting the binding of the TCR to the MHC-peptide complex. This 
phenomenon prevents the epitope from being recognized by the T cell and therefore 
renders the epitope cryptic (Moudgil & Sercarz, 2005). 
1.5 T cell epitope spreading 
There are many factors that contribute to the development of autoimmunity and one 
which has recently been studied is the phenomenon of epitope spreading. This process 
occurs when the immune response (i.e. aT cell response) to autoantigens become more 
diverse as the disease progresses; and can occur at the T and/or B cell level (Vanderlugt 
& Miller, 2002). T cell epitope spreading is the changing in specificity of the immune 
response to T cell epitopes. The phenomenon ofT cell epitope spreading revealed that the 
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immune response is dynamic and that T cells which recognize dominant epitopes, over 
time, can recognize formerly cryptic epitopes during the course of disease (Lehmann et 
a!., 1992). Since then, many studies on epitope spreading have been conducted revealing 
that there are two types of epitope spreading, intra- and intermolecular epitope spreading 
(Vanderlugt & Miller, 2002). Intramolecular epitope spreading has been defined as the 
spreading of an immune response from one epitope to another epitope on the same 
molecule or protein; and intermolecular epitope spreading is the change in specificity of 
an immune response from one molecule to another molecule. 
Epitope spreading can be initiated by chronic tissue damage through the activation and 
recruitment of autoreactive lymphocytes (Vanderlugt & Miller, 2002) or by the induction 
of chronic tissue pathology by viruses (Vanderlugt & Miller, 1996). Therefore, a primary 
response has to occur whereby the recognition of a primary epitope causes the activation 
and differentiation of autoreactive T helper type 1 (T H 1) cells. These cells migrate to the 
infected tissue, bind to APC, become activated and release cytokines, which cause tissue 
damage. Autoantigen complexed with autoantibodies is then processed differently and 
presented to APC which activate and differentiate a second wave ofT H 1 cells (Vanderlugt 
& Miller, 2002; Dai et al. , 2005). These cells can now reenter the infected area and cause 
more tissue damage due to the recognition of other previously cryptic epitopes ( epitope 
spreading) (Vanderlugt & Miller, 2002). 
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1.5.1 T cell epitope spreading in experimental autoimmune encephalomyelitis 
(EAE) and adjuvant arthritis (AA) 
The study ofT cell epitope spreading is a relatively new concept. It was first considered 
in 1992 by Lehmann et al. in their study on experimental allergic encephalomyelitis 
(EAE), the mouse model of multiple sclerosis (MS) (Lehmann et al., 1992). EAE is 
caused by the autoreactivity of CD4+ T H 1 cells to a single dominant myelin peptide 
determinant (Tuohy et al., 1999), either the CNS protein MBP, PLP or myelin 
oligodendrocyte glycoprotein (MOG) (Vanderlugt & Miller, 2002). Studies ofEAE have 
shown that during the course of chronic disease there is spreading of the T cell response 
from a single dominant peptide, to formerly cryptic peptides. Lehmann et al., first studied 
T cell epitope spreading in EAE by immunizing (SJL x B 1 O.PL)Fl mice with MBP and 
pertussis toxin (PTX, a requirement for the induction of EAE because it disrupts the 
blood brain barrier) (Lehmann et al., 1992). Results showed that there was evidence ofT 
cell epitope spreading from the dominant MBP:Acl-11 peptide, to cryptic MBP peptides, 
35-47, 81-100, and 121-140, i.e. the specificity ofthe T cell immune response was 
constantly changing (Lehmann eta!., 1992). The authors claimed that epitope spreading 
could be the reason that there is chronic disease, because the change in specificity for 
different epitopes in MBP by the T cells may lead to chronic tissue damage and the 
progression of EAE. Also, they noted that due to the constant generation of new epitopes, 
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it may be difficult to treat EAE using peptide-specific therapies (Lehmann et al., 1993; 
Vanderlugt & Miller, 1996; Vanderlugt & Miller, 2002). 
In 1997, Moudgil et al. tested T cell epitope spreading in the rat model of AA (Moudgil et 
al., 1997). They induced disease in Lewis rats by s.c. injection of M. tuberculosis H37Ra 
in IF A or mineral oil in their hind footpad. Lymph node cells (LNC) were tested forT 
cell reactivity against a panel of Bhsp65 peptides, during both the early and late phases of 
disease. They found that during the early phase (6-9 days), there were T cell responses 
detected against 13 Bhsp65 peptides which were either dominant or subdominant. During 
the late phase (8-1 0 weeks), they found that there were T cell responses to 16 peptides, 
with only 2 of the 16 peptides being recognized from the early phase. 
In this study we intended to investigate whether T cell epitope spreading occurs in EAT, a 
CD4+ T cell mediated disease. For this purpose we used several "cryptic" Tg peptides as 
markers to examine if the autoimmune response spreads toward them during the course of 
disease; in order to determine if cryptic T cell determinants are generated after the 
challenge of Tg in CF A in CBA/J mice. 
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CHAPTER2 
MATERIALS AND METHODS 
2.1 Animals 
Female CBNJ mice were purchased from Jackson Laboratories (Bar Harbour, ME, USA) 
and used at 7-8 weeks of age. Two breeding pairs ofNOD.H2h4 mice were a kind gift 
from Dr. H. Braley-Mullen. A NOD.H2h4 colony was established from these breeding 
pairs in our animal care facility. All experimental procedures were approved by the 
Animal Care Committee at Memorial University of Newfoundland. 
2.2 Antigen 
2.2.1 Tg purification 
One hundred mouse thyroid glands were placed in a 16 x 100 mm culture tube (Fisher-
Scientific, Ottawa, ON, CA) on ice in 5 ml of phosphate buffer saline (PBS) containing 
protease inhibitors (leupeptin 1 o-6 mol/L, pepstatin A 1 o-s mol/L, and PMSF 1 o-3 mol/L ; 
Sigma-Aldrich, St. Louis, MO, USA). Thyroids were homogenized in short bursts using 
a PCR tissue homogenizing kit (OMNI International, Marietta, GA, USA) and divided 
into 5 Eppendorf tubes each containing 1 ml of suspension. The tubes were spun three 
times at 14,000 rpm for 10 minutes and supernatants were removed and placed over a 
Sepharose CL-4B column (Amersham Biosciences, Bale d'Urfe, Quebec, CA). PBS with 
protease inhibitors was then run through the column and the sample was fractionated (2 
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minute intervals, 3.1 ml) in 13 x 100 mm tubes (Fisher-Scientific, Ottawa, ON, CA). The 
protein content of each fraction was read at an optical density (O.D.) of280 nm (Kim, 
Dunn, & Dunn, 1988). The second peak (660 kD) was collected and dialyzed in 1 L of 
Fisher W5-4 water for 4-6 hours, (HPLC grade; Fisher-Scientific, Ottawa, ON, CA) three 
times, with one dialysis period being overnight. Tg was concentrated using an Amicon 
ultrafiltration cell (Amicon, Danvers, MA, USA) to ~1 mglml, placed in Eppendorftubes 
(1 mlltube) and put into a SpeedVac concentrator SVC1 OOH (Savant Instruments Inc., 
Farmingdale NY, USA) to lyophilize the Tg. Once lyophilized, the Tg was placed in - 20 
2.2.2 Preparation of highly iodinated Tg (HI-Tg) 
Highly iodinated Tg (Hl-Tg) was prepared in our lab using Iodo-beads, following the 
manufacturer's instructions (Pierce Instruction Manual, Rockford, IL, USA). First, each 
bead was washed with 500 1-11 ofPBS and dried on filter paper. In a (16 x 100 mrn) glass 
culture tube containing 200 1-11 of PBS one bead was added. To the same tube, 20 1-11 of 
Nai (2.5 mM stock) was added and incubated for 5 minutes. Then, 200 !!g/200 1-11 ofTg 
was added to each tube and incubated for 30 seconds at room temperature while mildly 
agitating the tube. This procedure iodinates Tg so that it contains ~30-40 r 
atoms/monomeric subunit. After the incubation period, the solution was removed from 
the tube to stop the reaction and the bead was washed to ensure all the protein was 
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collected. The Tg solution was dialyzed 3 times with Fisher water (I L). The Tg was 
pooled and the h content was determined, as described in section 2.14. 
2.2.3 Tg peptides 
The sequences and amino acid coordinates of all peptides are shown in Table 2.1. 
Peptides pliO, pl579, and p1826 were synthesized by Sigma-Aldrich (St. Louis, MO, 
USA). Peptides p2495 and p2694 were synthesized by Alberta Peptide Institute 
(Edmonton, AB, CA) and all other peptides (p117, lp117, p179, lp179, p226, p304, p610, 
Ip610, p681, Ip681, p757, lp757, Ip1390, p1931 , Ip1931 , p 2026, Ip2026, Ip2529, p2540, 
Ip2540, p2617, & Ip2617) were synthesized by Dalton (Toronto, ON, CA). Each peptide 
was purified (to > 80%) by HPLC and analyzed by mass spectroscopy (Table 2.1). 
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Table 2.1 Tg peptides 
·-· 
Number a.a. coordin_ates Peptide synt':!_~si~ed Peptide denotation 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
'"! 
107-121 
121-130 
121-130 
182-192 
VQCDLQRVQ p110 
YQCWCVDTEGMEVYGT pll7 
--~-'V CWCVDTEGMEVY(!)C!1 _}pl l7 
NTIDMMIFDLIHNYNR p179 
. -
lp179 1182-192 
228-239 LAETGLELLLDEIYDTI 
. ---
306-316 SJl!_YQT~9CQTEG~CW 
612-620 QCY AG_ECW~VDSR9K 
612-620 QCY(I)AGECWCVDSRGK 
684-689 SECYCVDTEGQVIP 
684-689 SECY(I)CVDTEGQVIP 
~~65 
1
PHEQVFEWYERW 
758-765 PHEQVFEWY I ERW 
-·---- -~-
p2~6-
p304 
p610 
lp610 
p681 
lp681 
JP75~ 
. £~ -- -- -
~5 1577-1591 LVQCLTDCANDEA p1579 
... - -- -+ - - ----; -
16 1823-1837 GDMATELFSP p1826 
----· -- 4----
17 1935-1942 KVVLNDKVNNFYTRL p1931 
18 1935-1942 1ivVLNDKVNNFY(IyfRL lp1931 
19 2029-2035 GSEDTEVHTYP p2026 
20 2029-2035 GSEDTEVHTY(I)P lp2026 
t-·- 21 2495=2511 _ _ iGL~~JSA VKQFE~SQG p2495 
22 _ ~53.?-2543 . _ £.DSDARILAAA ~\YY(I)Y(I)SL lp2529 
23 2542-2552 .. fVWYYSLEHSTDDYAS 1p2540 
?_4 __ i35~2~2~52 ___ tvWY(i)Y(i)SLEH_§TDDY(I)AS ._lp254o ---
25 261~~6~~ _ _ SAYQGQF~EEQSL p2_?17 
26 2619-2626 _ ~A "\':C!2QGQ_FS'!'EEQ.§L . lp2617 
27 2694-2710 C(Acm)SFWSKYIQlLKDADGAK p2694 
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mTgP1 
1 _j --~ I 
TgP2 ** 
2.3 Culture media and cell lines 
Lymphocytes were cultured in complete medium which consisted ofDulbecco's 
Modified Eagle Medium (DMEM) supplemented with 100 U/ml penicillin, 100 ~g/ml 
streptomycin (Gibco Invitrogen, Grand Island, N.Y., USA), 10% fetal bovine serum 
[(FBS)(Cansera, Rexdale, ON, CA)], 5 x 10·5 M 2-mercaptoethanol (2-ME), and 20 mM 
HEPES buffer (Sigma-Aldrich, St. Louis, MO, USA). Bone marrow-derived dendritic 
cells (BM-DC) were cultured in complete medium which consisted ofRPMI-1640 
medium (Gibco Invitrogen, Grand Island, N.Y., USA) supplemented with 100 U/ml 
penicillin, 100 ~g/ml streptomycin, 10% FBS, 5 X 1 0"5 M 2-ME, and 10% supernatant 
from a cell line (X63Ag8; received as a gift from B. Stockinger, National Institute of 
Medical Research, London, U.K.) transfected with the murine granulocyte, macrophage, 
colony stimulating factor (GM-CSF) gene (Karasuyama & Melchers, 1988; Zal et al. , 
1994). The IL-2-dependent CTLL line (Gillis & Smith, 1977) was purchased from 
American Type Culture Collection, Manassas, VA, USA. The cells were cultured in 
complete DMEM + 10% IL-2-containing supernatant supplemented with methyl-a-D-
mannopyranoside (50 mM final; Sigma, St. Louis, MO, USA). This supernatant was 
produced by culturing naive (6 week old) rat splenocytes in complete media and 
concanavalin A (conA; 5 ~g/ml) for 48 hours in a flask at 37 °C. At the end of the 
incubation period, the supernatant was decanted and supplemented with methyl-a-D-
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mannopyranoside (50 mM) to inactivate any free conA. The supernatant was then filter-
sterilized and stored at -20 °C. 
2.4 Generation of CD4+ T ceU hybridomas 
Three CD4+ T cell hybridomas, 4A6.3, 1 OCl.l, and 1H7, were generated in vitro in our 
laboratory by immunizing CBA mice with 100 nmol ofTg peptide (I-p117, I-p304, and 1-
p 1931, respectively). Seven days later, the mice were sacrificed, caudal, lumbar and 
inguinal lymph nodes were removed and single cell suspensions were made by passing 
the lymph node tissue through a sterile stainless steel wire mesh (Sigma-Aldrich, St. 
Louis, MO, USA). The cells were cultured ( 4 x 106 cells/ml) in complete DMEM in l ml 
aliquots in Multidish 24 well plates (Nunc, Roskilde, Denmark) in the presence of 10 
J.!g/ml ofTg peptide. After 4 days of culture, the peptide primed lymphocytes were 
harvested, washed twice and placed in serum-free DMEM. The lymphocytes were fused 
with BW5147a-~- cells (White et al., 1989), a gift from P.Marrack (Howard Hughes 
Medical Institute, Denver, CO, USA), using 50% polyethylene glycol (PEG; Sigma-
Aldrich, St. Louis, MO, USA) at a 1:2 ratio ofT cells to tumor cells. 
In a sterile 50 ml polypropylene centrifuge tube (Coming Inc., Coming, NY, USA), cells 
were mixed at the required ratio to get a concentration of 2.5 x 105 total cells/ml and spun 
at 1200 rpm for 5 minutes. The cells were washed twice and the supernatant was 
discarded. The tube was held on an angle and 1 ml of prewanned 50% PEG was added 
drop-by-drop to the pellet over 1 minute, agitating gently after each drop. Next, 2 ml of 
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prewarmed serum-free DMEM was added over two minutes, agitating gently after each 
drop and 8 ml of prewarmed serum free DMEM was added over a 5 minute period, 
agitating gently after each drop. The tube was inverted several times to resuspend the 
pellet, the cells were centrifuged at 1000 rpm for I 0 minutes and the supernatant was 
discarded. The pellet was resuspended once with 10 ml of prewarmed DMEM + 20% 
FBS and more DMEM + 20% FBS was added until the cells were set at a concentration 
of 2.5 x 1 05 cells/ml. The cells were placed in a 96 well flat bottom plate ( 100 J..tllwell; 
Coming Inc, Coming NY, USA) and placed at 37 °C in a 10% C02, 90% air humidified 
incubator. Twenty-four hours later, 100 J.!l of 2x hypoxanthine-aminopterin-thymidine 
(HAT; Sigma-Aldrich, St. Louis, MO, USA) - containing DMEM + 20% FBS was added 
to each well. The cells were monitored daily and fed approximately every 5 days with 
100 J.!l of lx HAT-containing complete media (hybrids appeared between 7-21 days). 
When the cells reached Y2 - :X confluency, they were transferred ( 1 ml aliquots) to a 
sterile Falcon multiwell (6 well) plate (Becton Dickinson Labware, Franklin Lakes, NJ, 
USA) in 1 x HAT medium. After 4-5 days, the HAT media was replaced with 1 x 
hypoxanthine-thymidine (HT; Sigma-Aldrich, St. Louis, MO, USA) media for at least 2 
cycles and then to DMEM + 10% FBS. Cells in wells that reached 75% confluency were 
tested for reactivity against the specific Tg peptide. To test for reactivity, an activation 
assay was preformed as described in section 2.13. The antigen-specific hybridomas were 
cloned by limiting dilution at 0.3 cell/well using 1% syngeneic red blood cells (RBC) as 
filler cells as described in section 2.5 (Rao et al., 1994). 
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2.5 Subcloning ofT cell hybridomas by limiting dilution 
The cells were harvested and washed 2 times with DMEM. Cells were resuspended in 
DMEM + 20% FBS, counted and set at a starting concentration of 3 x 104 cells/mi. The 
cells were serially diluted ten-fold until the final concentration was 3 cells/ml (0.3 T 
cells/well). Blood from a CBA/J mouse was collected (0.3 ml) and the RBC were used as 
filler cells. The RBC were washed once in 10 ml ofDMEM, resuspended in DMEM + 
20% FBS, and added to the final tube of cells (1% syngeneic RBC as filler cells). In a 96 
well flat bottom plate, 100 Ill of the RBC/cell mixture was added to each well and 
incubated at 3 7 °C in a 10% C02, 90% air humidified incubator. Seven and 12 days later, 
50 J.ll of DMEM + 20% FBS was added to each well. After 14 days, if growth was 
evident, the cells were transferred into a 24 well plate. Once the cells reached 75 % 
confluency in the well, they were tested for reactivity against 1 J.lM of their specific Tg 
peptide. This method is described in section 2.13. 
2.6 Induction of experimental autoimmune thyroiditis (EAT) 
CBA/J mice were immunized s.c. in the back of the neck and base ofthe tail with 100 J.ll 
of emulsion containing 200 j.lg of Tg in CF A (with Mycobacterium butyricum; Difco 
Laboratories, Detroit, MI, USA) on day 0. Half of the mice were boosted on day 21 with 
100 j.lg ofTg in IFA (Difco Laboratories, Detroit, MI, USA) (Chronopoulou & 
Carayanniotis, 1992). On days 7, 21, 28, 35, and 42, the mice were sacrificed; thyroids 
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were removed, sectioned, stained, and analyzed for mononuclear cell infiltration as 
described in section 2.10. 
2.7 Induction of iodine-accelerated spontaneous autoimmune thyroiditis 
(lA-SAT) 
NOD.H2114 mice were given water containing 0.05% Nal (Sigma-Aldrich, St. Louis, MO, 
USA) for a period of 8 weeks, starting at 6-8 weeks of age. After 8 weeks, mice were 
euthanized and thyroids were removed, sectioned, stained and analyzed for mononuclear 
cell infiltration as described in section 2.10 (Rasooly et al., 1996). 
2.8 T cell proliferation assays 
Seven days after immunization with Tg in CFA, draining lymph nodes (LN; inguinal, 
brachial, and axillary) were collected and single cell suspensions (LNC) ( 4 x 105 
cells/well/1 00 J.ll) were made. LN cells (LNC) were cultured with Tg (1 00 J.lg/ml) or Tg 
peptides ( 10 J.l.M), in 200 J.ll final volume in 96-well flat bottom plates. On days 21, 28, 
35, and 42, T cell proliferation assays were performed using RBC lysed-splenocyte 
suspensions (8 x 105 cell/well) in 200 J.ll final volume. ForT cell proliferation assays 
using NOD.H2h4 cells, all mice were sacrificed after 8 weeks on normal or Nal-water and 
thyroid draining cervical LN (TDCLN) or spleen were removed. Whole lymphocyte (4 x 
1 05 cells/well/1 00 J.ll), splenocyte (8 x 105 cells/well/1 00 J.ll) and enriched splenic CD4+ T 
cell populations were cultured in the presence or absence of Tg (1 00 J.lg/ml), 1-Tg (32.5 
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J...Lg/ml) or Tg pep tides (1 0 !J.M). In cultures using enriched populations of CD4+ T cells 
(105 cells/well/50 !J.l), syngeneic mitomycin-C (Sigma-Aldrich, St. Louis, MO, USA)-
treated splenocytes (3 x 105 cells/well/50 !J.l) were used as an APC. All cells were 
cultured in complete DMEM and placed at 37 °C in a 10% C02 90% air humidified 
incubator for 4 days. Eighteen hours before harvesting, 1 !J.Ci of 3[H]-thymidine (6.7 
Ci/mol; PerkinElmer, Boston, MA, USA) was added to each well in 25 Ill of medium 
(Lehmann et al., 1992). The cells were harvested and thymidine incorporation was 
measured using a Beckman Coulter LS 6500 Multi-Purpose Scintillation Counter. 
Stimulation indices (SI) were measured as: (cpm in the presence of antigen)/(cpm in the 
absence of antigen) (Chronopoulou et al., 1992). 
2.9 Separation of CD4+ T cells from spleen 
Single cell suspensions were made from the spleens ofNOD.H2h4 mice and enriched 
CD4+ T cell populations were negatively selected using an EasySep mouse CD4+ T cell 
enrichment kit, following the manufacturer's instructions (Stem Cell Technologies Inc. , 
Vancouver, BC, CA). This method specifically labels unwanted cells (non-CD4+ T cells) 
with dextran-coated magnetic nanoparticles by using biotinylated antibodies against cell 
surface antigens expressed on the unwanted cells. The bispecific Tetrameric Antibody 
Complex (TAC) recognizes both biotin and dextran and therefore, anti-biotin Ab binds to 
biotin on the unwanted cells and anti-dextran Ab binds to dextran on the magnetic iron 
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nanoparticles. These labeled cells become trapped on the sides of the tube when place 
into the magnetic field and allow target cells to be separated. 
Briefly, RBC-depleted splenocytes were washed with PBS and placed in PBS + 5% 
normal rat serum at a concentration of 108 cells/ml in a 12 x 75 mm sterile Falcon tube 
(Fisher-Scientific, Ottawa, ON, CA). Rat serum was used to prevent non-specific binding 
of rat Ab to mouse cells. Next, 50 Ill of mouse-CD4+ enrichment cocktail was added and 
the cells were incubated in the dark at 4 oc for 15 minutes. Next, 100 Ill of biotin 
selection cocktail was added and the cells were incubated for 15 minutes in the dark at 4 
oc. After 15 minutes, 50 Ill of magnetic nanoparticles were added to the cells and they 
were incubated in the dark for 15 minutes at 4 °C. The mixture was topped up to 2.5 ml 
with PBS + 2% FBS and placed in an EasySep magnet for 5 minutes to attract the 
magnetically labeled cells to the sides of the tube. The magnet containing the tube was 
inverted for 2-3 seconds and the CD4+-enriched cells were poured into a new steri le tube 
and used in T cell proliferation assays. 
2.10 Histology 
EAT was induced in CBA/J mice by immunization with Tg in CF A, as described in 
section 2.6. The thyroid glands were removed, still attached to the trachea, and placed in 
10% formalin (Fisher-Scientific, Ottawa, ON, CA). The lobes of the thyroid were 
dissected from the trachea, embedded in methacrylate, and sectioned at 3.0 IJID intervals. 
The sections were placed on slides, 7 sections per slide, stained with haematoxylin and 
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eosin (H&E), and analyzed for mononuclear cell infiltration. Infiltration indices (1.1) 
were scored as follows: 0 = no infiltration, 1 = interstitial accumulation of cells between 
two or three follicles; 2 = one or two foci of cells, the size of a follicle; 3 = extensive 
infiltration, 10-40% of total area; 4 = extensive infiltration 40---80% of total area; and 5 = 
extensive infiltration >80% of total area (Verginis et al., 2002). 
2.11 Enzyme-linked immunosorbent assays (ELISA) 
Upon sacrifice, blood was collected by heart puncture and spun at 1200 rpm for 10 
minutes. The serum was collected, stored at -20 OC, and used to detect the presence of 
speci fie IgG Ab by ELISA. Disposable polyvinyl chloride plates (Dynex Technologies 
Inc., Chantilly, VA, USA) were coated overnight (1 00 ).!1/well) at 4 oc with 1 0 ).lg/ml of 
Tg, HI-Tg, or 1 ).!M ofTg peptide diluted in carbonate buffer, pH 9.6 (Sigma-Aldrich, St. 
Louis, MO, USA). The plates were washed with PBS and blocked with 0.1% BSA + 
PBS (200 ).!1/well) for 1 hour at room temperature. Then the plates were washed with 
PBS-Tween (PBS-T; Sigma, St. Louis, MO, USA) and 0.1% BSA + PBS-T was added 
(1 00 ).lllwell) to all wells except the first row. Sera samples at an optimum starting 
dilution were added (100 ).lllwell) to the first row, serially diluted 2-fold, and incubated 
for 1 hour at room temperature. The plates were washed three times with PBS-T, and a 
secondary antibody, goat anti-FC of mouse lgG (1 00 ).!1/well; Sigma-Aldrich, St. Louis, 
MO, USA) diluted at 1/2000 was added. The plate was incubated in the dark for one 
hour. The plates were washed three times with PBS-T and 100 ).ll of substrate solution (1 
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mg/ml p-nitrophenyl phosphate in 10% diethanolamine buffer; Sigma, St. Louis, MO, 
USA) was added to each well and incubated for 30 minutes. The absorbance of the p-
nitrophenylate product was measured at 405 nm using a Vmax, kinetic microplate reader 
(Molecular Devices, Sunnydale, CA, USA) (Chronopoulou eta!., 1992). 
2.12 Generation of bone marrow-derived dendritic cells (BM-DC) 
Bone marrow (BM) was extracted from the tibia and fibia ofNOD.H2h4 mice, and RBC 
were lysed with Tris-NH4Cl (0.161M Tris-NH4Cl; 0.1m1 packed cells/ml Tris-NH4Cl) for 
2 minutes, under-layed with FBS, and centrifuged for 10 minutes at 1200 rpm. The 
resulting cells were washed 3 times with RPMI-1640 medium and were seeded at 2 x 106 
cells/1 00 mm Petri dish (Coming Inc, Coming NY, USA). The cells were cultured in 10 
ml RlO medium (RPMI-1640 + 10% FBS) + 10% GM-CSF and placed at 37 oc in a 5% 
C02, 95% air humidified incubator. On day 3, 10 ml ofRlO + 10% GM-CSF was added 
to each plate. On days 6 and 8, half of the culture supernatant was removed, centrifuged, 
the pellet was resuspended in fresh RIO + 10% GM-CSF media, and the cells were placed 
back into their original dishes. After 10 days of culture, the nonadherent cells were 
gently dislodged by pi petting and used in activation assays (Lutz eta!., 1999). 
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2.13 Hybridoma T -cell activation assay 
Cloned hybridoma T cells (1 05 cells/well, 50 111/well) and BM-DC (1 05 cells/well, 
50!11/well) were harvested, washed 3 times, and cultured for 24 hours in the presence or 
absence of 100 111 of 1 11M Tg, 1-Tg, or Tg peptides (specific or control peptide). After 24 
hours, 1 00 111 of supernatant was removed from each well, put into a new 96 well flat 
bottom plate, and placed at -20 °C for overnight. Frozen supernatants were later thawed 
and their IL-2 content was measured by the proliferation of CTLL cells. The CTLL cells 
were washed 4 times (to remove any leftover IL-2) and adjusted to 105 cells/mi. The cells 
(1 04 cells/well) were placed in wells containing either supernatant, complete DMEM 
(negative control), or complete DMEM + 10% Con A supernatant (positive control) and 
incubated for 24 hours at 37 °C, in a 10% C02, 90% air humidified incubator (Dai et al. , 
1999). Six hours before harvesting, l11Ci of 3[H]-thymidine was added to each well, the 
cells were harvested, and 3[H]-thymidine incorporation was measured as described in 
section 2.8. 
2.14 Determination of iodine content in Tg 
Free iodine was removed by extensive dialysis and the Tg-incorporated iodine was 
measured using a modified nonincinerative technique based on the catalytic activity of 
iodine in the eerie (Ce)-arsenite (As) reaction (Palumbo et al. , 1982; Saboori et al., 1993). 
Mouse Tg (16 11g) was dissolved in 50% glacial acetic acid (Baxter Corporations, 
Toronto, ON, CA) in a 3 ml cuvette (Fisher-Scientific, Ottawa, ON, CA) to give a final 
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volume of0.4 ml. To the cuvette, 160 Ill of H2S04 (36.7 N; BDH Inc., Toronto, ON, CA) 
was added, the cuvette was sealed, mixed by shaking, and incubated at room temperature 
for 10 minutes. Next, 80 Ill of 1 mM Br2 (Sigma-Aldrich, St. Louis, MO, USA) was 
added and incubated at room temperature for 15 minutes. After 15 minutes the cuvette 
was placed into the spectrophotometer and 80 Ill of Ce/NH4S04 solution (Acros Organics, 
Morris Plains, New Jersey, USA) was added immediately, followed by 0.8 ml of 10 mM 
NaAs02 (Fisher-Scientific, Ottawa, ON, CA). The reagents were immediately mixed and 
after 13 seconds the absorbance was read at an O.D. value of 410 nm. One minute later, 
another reading of the cuvette was taken. Spectrophotometric analysis of the reduction of 
Ce (IV) to Ce (III) by As (III) showed a discoloration of the yellow Ce ion to a colorless 
ion. The results were then compared to a standard curve ofT4 (Sigma-Aldrich, St. Louis, 
MO, USA) which was constructed using known concentrations ofT4 dissolved in a 99 vol 
of absolute methanol (Fisher-Scientific, Ottawa, ON, CA) and 1 vol of30 % ammonium 
hydroxide (Sigma-Aldrich, St. Louis, MO, USA). The same procedure was used to 
determine the standard curve (Dai et a!. , 2002). The standard curve was plotted as the 
mean O.D. (initial reading OD - final reading OD) per minute versus IJM/400 Ill of 
iodine per sample. For normal Tg the expected number of iodine atoms/monomer was 
between 13-26 and maximally iodinated Tg was expected to contain -60-70 Iodine 
atoms/monomer. 
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CHAPTER3 
T CELL EPITOPE SPREADING IN MURINE EAT 
3.1 ABSTRACT 
EAT, the murine model of Hashimoto's thyroiditis, can be induced in CBA/J mice after 
challenge with Tg in CF A. To date, at least 23 non dominant pathogenic T -cell epitopes 
have been discovered within the large (2749 aa) Tg molecule (Carayanniotis, 2007). 
However, the concept ofT-cell epitope spreading has not been tested in EAT, as it has 
been in other animal models of autoimmune disease. To test this, we immunized CBNJ 
mice with 200 )lg Tg in CPA and 7, 21, 28, 35, and 42 days later, mice (2 mice per time 
point) were sacrificed and spleen, lymph nodes, and sera samples were obtained. 
Mononuclear cell infiltrates of the thyroid were detected at all time points tested, but, Tg-
specific proliferative T-cell responses were detected only on day 7 after challenge. 
Screening against a panel of 18 non-dominant pathogenic Tg peptides and their iodinated 
analogues showed that a significant T -cell response to these Tg peptides could not be 
generated up to 42 days after challenge. These results suggest that T-cell epitope 
spreading does not occur in CBNJ mice 42 days after challenge with Tg in CF A. 
35 
3.2 INTRODUCTION 
The phenomenon ofT cell epitope spreading has been observed in many T cell-mediated 
diseases. One disease in particular, EAE, has been extensively studied in regard to T cell 
epitope spreading. Studies using this model have revealed that the T cell immune 
response in EAE is dynamic, shifting from the recognition of a single dominant peptide to 
other cryptic peptides as the disease progresses (Lehmann et al., 1992). The 
diversification of the T cell repertoire due toT cell epitope spreading in EAE has 
suggested: 1) a mechanism for the pathogenesis ofT-cell driven autoimmune disease and 
2) a possible therapeutic approach to prevent T-cell driven autoimmune disease before T 
cell epitope spreading occurs (Lehmann eta/., 1992). Lehmann et a/. (1992) suggest that 
by inactivating the first wave of peripherally primed effector T cells this will prevent 
second-wave priming to autoantigens and prevent T cell epitope spreading (Lehmann et 
a/., 1992). Tg-induced EAT, another T cell-mediated disease, is characterized by the 
destruction of the thyroid gland by mononuclear cell infiltration. Like EAE, Tg-induced 
EAT does not occur spontaneously, requiring an immunization with Tg in CF A (Rose & 
Witebsky, 1956). Tg, the largest autoantigen in EAT, is composed of 2749 a.a. (Dunn & 
Dunn, 2000). Since the discovery ofTg by Roitt eta/. (Roitt et al. , 1956), a total of23 
known pathogenic Tg peptides have been mapped within the huge molecule 
(Carayanniotis, 2007). Unfortunately, a dominant Tg peptide has yet to be discovered in 
the Tg molecule. Of the 23 Tg peptides mapped, all are immunopathogenic, but cryptic 
(Carayanniotis, 2007). Therefore, Tg-primed T cells are not activated by Tg peptides and 
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Tg peptide-primed T cells are not consistently activated by Tg in vitro. To date, there are 
three different categories ofTg peptides: 1) noniodinated peptides, 2) iodinated peptides 
containing hormonogenic sites, and 3) iodinated peptides containing iodotyrosyls (Li & 
Carayanniotis, 2006; Carayanniotis 2007). It is known that smaller doses ofTg peptide 
are required (50-200 nmol) to exert similar pathogenic effects on T cells than whole Tg 
(20-1 00 ~J.g/61-303 IJ.mol) (Carayanniotis, 2007). In order to make our results valid and 
reliable we used equimolar concentrations of whole Tg and Tg peptide to ensure that 
there were an equal number of molecules of each substance used when testing T cell 
reactivity. 
In our study, we wanted to determine ifT cell epitope spreading occurs in Tg-induced 
EAT in CBA/J mice. We hypothesized that over the course of 6 weeks, CBA/J mice 
challenged with Tg in CFA will show spreading of the immune response to cryptic Tg 
peptides. We also wanted to determine if boosting had an effect on T cell epitope 
spreading in Tg-induced EAT in CBA/J mice because boosting is an essential 
requirement for the optimal induction of EAT. 
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3.3 RESULTS 
3.3.1 Induction of EAT in CBA/J mice 
CBNJ mice were immunized subcutaneously with 200 llg Tg in CF A and 2 mice per 
time point were sacrificed on days 7, 21, 28, 35, and 42. Thyroids were removed and 
placed in fonnalin, histologically sectioned and stained, and scored for mononuclear cell 
infiltration. In the first experiment (days 7 -42), all 10 mice tested had mononuclear cell 
infiltration in the thyroid gland ranging from 1-3 (Table 3.1). Also, there was no 
significant difference between early and late time periods with respect to mononuclear 
cell infiltration in the thyroid gland (p > 0.05). In the second experiment (Table 3.2), 
13/14 mice developed thyroiditis with an I. I. of 1-4. These data confirmed that EAT was 
successfully induced in all mice through immunization with Tg in CF A and that the time 
of sacrifice did not have an effect on the development of disease (Figure 3.1). 
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Table 3.1. Induction of EAT in CBA/J mice after receiving a single injection of 200 
11g ofTg in CFA. 
Direct induction of EAT 
Infiltration index (1.1.) 
Day 0 1 2 3 No. of mice with EAT 
7 0 1 0 1 2/2 
21 0 1 0 1 2/2 
28 0 2 0 0 2/2 
35 0 1 0 0 111 * 
42 0 1 1 0 2/2 
N/D for one mouse 
Thyroids were histologically sectioned, stained with H&E and infiltration indices (I.I.) 
were scored according to the level of destruction in the thyroid gland by mononuclear cell 
infiltration. 
Table 3.2. Confirmation of EAT induction in CBA/J mice after receiving a single 
injection of 200 11g of Tg in CF A. 
Direct induction of EAT 
Infiltration index (I.I.) 
Day 0 1 2 3 4 No. of mice with EAT 
7 1 1 0 0 0 112 
21 0 0 1 0 1 2/2 
28 0 0 2 0 0 2/2 
35 0 0 2 0 0 2/2 
42 0 1 1 0 0 2/2 
56 0 0 1 1 0 2/2 
70 0 2 0 0 0 2/2 
Thyroids were histologically sectioned, stained with H&E and infiltration indices (I.I.) 
were scored according to the level of destruction in the thyroid gland by mononuclear cell 
infiltration. 
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Figure 3.1. Histological appearance of mononuclear cell infiltration in thyroid 
glands of CBA/J mice after a single injection with Tg in CFA. Infiltration indices 
(1.1.) were scored as outlined in materials and methods. (A) I.I. = 3, day 7, 40X; (B) I.I. = 
2, day 21 , 40X; (C) I. I. = 1, day 42, 40X. 
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3.3.2 Antibody response to mTg 
Serum was collected during each time period and ELISA was perfonned to measure the 
level of IgG Ab specific for mTg. Only individual sera, diluted at 1 :200, from mice in the 
first experiment were tested. All mice given injections ofTg in CF A produced very high 
levels of IgG Ab in their serum against mTg compared to the sera taken from two na·ive 
control CBA/J mice which did not produce Ab to mTg. The two control mice were 
sacrificed on day 42 of the experiment at 3-4 months of age and only serum was collected 
for testing. Also, the level of antibody increased as disease progressed. This was evident 
with an 0.0. reading of 1 on day 7, to 3.5 on days 35 and 42 (Figure 3.2). Sera were also 
tested against OVA in which no IgG Ab responses were detected, data not shown. 
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Figure 3.2. Serum lgG response against mouse Tg in CBA/J mice after a single 
chaUenge with Tg in CFA. Sera were collected from two nai've CBA/J mice (control) on 
day 42 and compared to ten CBA/J mice immunized with Tg in CF A on the days 
indicated (2 mice/group). Tg ELISA was performed to measure the specific IgG response 
to Tg. Individual sera were obtained from mice of Table 3.1 and were used at a starting 
dilution of 1 :200. The O.D. was measured at 405 nm after 15 minutes. 
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3.3.3 T cell epitope spreading after a single s.c. challenge with Tg 
CBA/J mice of Table 3.1 and 3.2 had their lymph nodes (day 7) or spleens removed at the 
time of sacrifice. T cell proliferation assays were conducted using whole populations of 
cells cultured in the presence or absence of 18 cryptic, but pathogenic Tg peptides and 
their iodinated analogues (Table 2.1) or whole Tg. T cell epitope spreading did not seem 
to occur in EAT, 6 weeks after immunization with Tg in CFA, because the T cells from 
CBA/J mice did not recognize any of the Tg peptides tested (Figure 3.3). These results 
were confirmed, however, histology was not performed on the thyroids of these mice. 
Two later time points (days 56 and 70) were also tested to ensure that T cell epitope 
spreading was not delayed in this model (Figure 3.4). In this second experiment the 
observed T cell responses to the Tg peptide p 179 were not biologically meaningful 
because this Tg peptide also stimulated naive CBA/J T cells (Figure 3.5) suggesting a 
non-specific effect. Collectively, these data provide no evidence for spreading of the 
immune response after challenge with intact Tg. 
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Figure 3.3. T cell epitope spreading does not occur in CBA/J mice after 6 weeks of 
priming with Tg in CFA. Female CBA/J mice (2 mice per time point) were immunized 
with Tg in CF A and sacrificed on the days shown. T cell proliferation assays were 
conducted using whole populations of spleen (8 x 105 cells/well; days 21 , 28, 35, & 42) 
and lymph node cells ( 4 x 105 cells/well; day 7), cultured with a panel of 27 Tg peptides 
for 4 days. During the last 18 hours of culture, 3[H]thymidine was added (1 !J.Ci/well) and 
the cells were harvested after 96 hours of culture. S.I. were measured as follows: ( cpm in 
the presence of A g)/ ( cpm in the absence of A g). 
44 
7 
Day?O 
6 
5 
4 
3 
2 
Figure 3.4. Lack ofT cell epitope spreading 56 and 70 days post-immunization with 
Tg in CFA. T cell proliferation assays were conducted using splenocytes from female 
CBNJ mice immunized with a single injection ofTg in CFA and cultured in the presence 
or absence of a panel ofTg peptides and Tg. 
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Figure 3.5. T cell reactivity to p179 in na'ive CBA/J mice. Nal've splenocyte 
populations were cultured in the presence or absence of p 179 for 4 days. S.l. were scored 
for p179 (S.I. = 3.3) and t-tests were performed (p < 0.0018). 
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3.3.4 T cell epitope spreading after two challenges with Tg 
It is well known that EAT is routinely induced in CBA/J mice after two injections ofTg, 
one in CFA and the other in IFA (Charreire, 1989; Weetman & McGregor, 1984; 
Weetman & McGregor, 1994). We decided to test T cell epitope spreading in Tg-induced 
EAT in CBA/J mice after two challenges with Tg to determine if the number of 
challenges had an effect on T cell epitope spreading in this model. CBA/J mice were 
immunized with Tg in CF A on day 0 and boosted with Tg in IF A on day 21. On days 28, 
35, and 42, two mice were sacrificed and thyroids, blood and serum were removed. T cell 
proliferation assays were conducted using whole splenocyte populations cultured in the 
presence or absence of27 pathogenic, but cryptic Tg peptides and their iodinated analogs 
or whole Tg. According to our findings, we found that boosting had no effect on T cell 
epitope spreading in CBA/J mice. There was no significant T cell responses to any of the 
Tg peptides tested after 6 weeks of receiving their first immunization (Figure. 3.6). 
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Figure 3.6. Lack ofT cell epitope spreading in CBA/J mice after 2 challenges with 
Tg. CBNJ mice were immunized with Tg in CF A on day 0 andre-challenged with Tg in 
IFA on day 21. On days A) 28, B) 35, and C) 42, two mice were sacrificed and T cell 
proliferation assays were conducted using whole splenocyte populations cultured in the 
presence or absence of Tg and Tg peptides. 
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3.4 DISCUSSION 
To date, T cell epitope spreading has not been tested in Tg-induced EAT, but it has been 
studied in other animal models of autoimmune disease. We tested T cell epitope 
spreading in Tg-induced EAT, using CBA/J mice immunized with Tg in CFA. One 
experiment revealed that T cell epitope spreading does not occur in EAT, up to 6 weeks 
after immunization with Tg in CFA in CBA/J mice. This was evident in the lack ofT cell 
reactivity to a panel of 18 pathogenic, but cryptic Tg peptides and their iodinated 
analogues; this experiment was conducted three times with similar results. It is known 
that iodine can have variable effects on Tg peptides of known immunogenicity in regard 
to an increase, decrease or no change in antigenic or immunogenic response (Li & 
Carayanniotis, 2006). The I. I. scores and the production of IgG to mTg suggest that EAT 
was successfully induced in all mice tested, after immunization with Tg in CF A. 
Therefore, the lack ofT cell epitope spreading in this model is not due to unsuccessful 
induction of disease. We also tested if boosting with Tg in IF A, three weeks after 
primary challenge might have an effect on T cell epitope spreading in Tg-induced EAT. 
These results were similar to the results obtained from the non-boosted mice, i.e. we 
found no evidence ofT cell epitope spreading using the panel of 18 Tg peptides and their 
iodinated analogs. From these findings we conclude that boosting had no effect on T cell 
epitope spreading in CBA/J mice with EAT. Although T cell epitope spreading was not 
detected in Tg-induced EAT, 6 weeks post-injection, there was no T cell response to any 
of the 18 Tg peptides tested even after 56 and 70 days. The response top 179 was deemed 
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biologically insignificant because it occurred even with naive CBNJ mouse T cells 
suggesting the presence of contaminants with stimulatory properties. 
Although the results show that Tg-primed T cells do not recognize our panel ofTg 
peptides, we cannot rule out T cell epitope spreading in EAT as other unknown Tg 
peptides may be recognized. However, the lack of aT cell response to Tg after 21 days 
may indicate that ifTg is the autoantigen involved in initiating EAT, it may not be 
involved in maintaining this disease. The fact that CBNJ mice developed EAT shows 
that the lack ofT cell epitope spreading was not due to lack of immunogenic stimulus, but 
that these peptides are not generated after the processing ofTg in vivo. 
3.5 FUTURE DIRECTIONS 
Tg is a large molecule and may contain many more T cell epitopes. Testing such epitopes 
as potential targets during the course of EAT may be required to determine ifT cell 
epitope spreading occurs in Tg-induced EAT. Also, the discovery of a dominant Tg 
peptide would aid in testing T cell epitope spreading in this model. That way, one could 
monitor the spreading of the immune response from a dominant peptide to other cryptic 
Tg peptides during the progression of disease. 
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CHAPTER4 
THE ROLE OF Tg IN IODINE-ACCELERATED SPONTANEOUS 
AUTOIMMUNE THYROIDITIS 
4.1 ABSTRACT 
NOD.H2114 mice develop iodine-accelerated spontaneous autoimmune thyroiditis (IA-
SAT) after ingesting Nal in their drinking water for 8 weeks. IA-SAT causes the 
destruction of the thyroid by mononuclear cell infiltration and the production of 
thyroglobulin (Tg)-specific antibodies (Ab) in the serum. Tg, a target autoantigen in 
spontaneous autoimmune thyroiditis (SAT) and IA-SAT, can store available iodine in 
iodotyrosyl residues. In this study, we wanted to determine if our panel of Tg peptides are 
involved in the development and/or maintenance ofiA-SAT in NOD.H2h4 mice. We 
tested whether T cells from NOD.H2h4 mice given 0.05% Nal in their drinking water for 
8 weeks could recognize a panel of pathogenic, iodinated or non-iodinated Tg peptides 
when cultured in vitro. We found that while NOD.H2h4 mice develop lA-SAT and Tg-
specific Abs, their lymph node, splenic and purified CD4+ T cells do not recognize our 
panel ofTg peptides revealing that these peptides are not involved in lA-SAT 
development. Although there is strong evidence that Tg is a target autoantigen forT cells 
in EAT and forB cells in IA-SAT, our results do not provide evidence forT cell 
reactivity against our panel of pathogenic Tg epitopes. 
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4.2 INTRODUCTION 
NOD.H2h4 mice were derived by crossing NOD(H2g7) mice with B10.A(4R)(H-2h4) mice 
and then backcrossing the heterozygous progeny expressing the A k gene with NOD mice 
for many generations (Podolin et al. , 1993). After 6 generations, brother-sister matings 
occurred which resulted in the generation ofNOD.H2h4 mice. These mice were shown to 
develop SAT after 6 months of age, but no diabetes (Podolin et al., 1993). However, 6-8 
week old NOD.H2h4 mice placed for 8 weeks on drinking water with 0.05% Nal, develop 
SAT with accelerated onset and increased severity of lA-SAT as well as high Ab titers to 
mTg (Braley-Mullen eta!., 1999; Rasooly et al., 1996). 
Tg, the major autoantigen in autoimmune thyroiditis, is a large homodimeric molecule 
weighing ~660 kDa (Dunn & Dunn, 2000). An important feature ofTg is that it can 
incorporate and store available h in the form of iodotyrosyl residues (Dunn, 1995) which 
are required in the formation of the thyroid hormones T3 and T4 . Since the discovery of 
Tg, there have been a total of23 pathogenic, but cryptic Tg peptides identified 
(Carayanniotis, 2007). Iodination of some of these Tg peptides has had various influences 
on their immunogenicity and antigenicity, whereby iodination either causes an increase, 
decrease or no change in the Tg peptides immunogenic response (Li & Carayanniotis, 
2006). Quite a few of these pep tides are A k -restricted, but it remains unknown whether 
they are targets ofthe autoimmune response in NOD.H2h4 mice (they contain the Ak 
allele). Interestingly, highly iodinated Tg (HI-Tg) has been found to be more 
immunogenic than normal Tg, suggesting that it may harbor iodine-modified epitopes 
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(Dai et al., 2002). Based on the above rationale we hypothesized that iodinated Tg 
peptides may be preferential targets in lA-SA Tin NOD.H2h4 mice, and we proceeded to 
test their antigenicity at the B and T cell level. 
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4.3 RESULTS 
4.3.1 Iodine-accelerated SAT (lA-SAT) 
Male and female NOD.H2h4 mice (6 mice/group) were given 0.05% Nal water at 6-8 
weeks of age for a period of 8 weeks and control mice (6 mice/group) received normal 
water. After 8 weeks, the mice were sacrificed and thyroids were removed. The thyroids 
were placed in 10% formalin and histologically sectioned and stained to determine the 
level of mononuclear cell infiltration in the gland. Histological analysis of the thyroids 
confirmed that NOD.H2h4 mice develop SAT at an accelerated rate after drinking Nal 
water for 8 weeks. All male NOD.H2h4 mice given Nal water developed thyroiditis with 
an 1.1. of 4 (Table 4.1 and Figure 4.1). Female mice on Nal water also developed 
thyroiditis, but it was less severe, ranging from an I. I. of 1-3, with one mouse not 
developing thyroiditis. In the male control group, thyroiditis was significantly lower with 
only 2 out of 6 males developing disease, the highest having an I. I. of 2. However, in the 
female control group, 4 out of 6 females developed thyroiditis and there was no 
significant difference in 1.1. scores among the two female groups. 
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Table 4.1: NOD.H2114 mice given 0.05% Nal water for 8 weeks develop lA-SAT. 
Infiltration Index {I.Il 
Total mice with 
Mice a 0 1 2 3 4 SAT 
Male Nal 0 0 0 0 6 6/6] 
Female Nal 1 1 2 2 0 •• [ 5/6 'p < 0.05 
Male Controls 4 1 0 0 p > 0.05 2/6 
Female Controls 2 l 2 0 4/6 
aMale and female NOD.H2114 mice at 6-8 weeks of age were given normal water or water 
containing 0.05% Nai for a period of8 weeks. At 14-16 weeks of age, the mice were 
sacrificed and thyroids were removed, histologically sectioned, stained with H&E, and 
analyzed for mononuclear cell infiltration in the gland. 
blnfiltration indices (I.I.) were scored according to the scale provided in Materials and 
Methods. 
*t-test analysis of differences in severity of thyroiditis among males on Nal water and 
males on nonnal water, p < 0.05 
*'"t-test analysis of differences in severity of thyroiditis among females on Nai water and 
females on nonnal water, p > 0.05 
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Figure 4.1. Iodine-accelerated SAT in the thyroids of male and female NOD.H2114 
mice given 0.05% Nal for 8 weeks. Mice were given 0.05% Nal water at 6-8 weeks of 
age. After 8 weeks on water, mice were sacrificed and thyroids were removed and placed 
in 10% fonnalin. The thyroids were histologically sectioned and stained with H&E. 
Infiltration indices were scored as described in Materials and Methods. A) 1.1. = 4 (male), 
lOOx; B) 1.1. = 3 (female), lOOx; C) 1.1. = 1 (male), lOOX; and D) 1.1. = 0 (male), lOOX. 
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4.3.2 Antibody response to mTg, HI-Tg, Tg peptides and iodinated analogs 
Sera were collected from 14-16 week old NOD.H2114 mice at time of sacrifice to assay for 
the presence of IgG to Tg and HI-Tg to determine if the h content of Tg influences the 
antigenicity ofTg in lA-SAT. The pooled sera from each group were used at a starting 
dilution of 1:100. Our results show that male and female NOD.H2114 mice on 0.05% Nai 
water for 8 weeks mounted equivalent IgG responses against Tg (Figure 4.2 (A, B)) and 
HI-Tg (Figure 4.2 (C, D)). Control mice did not develop Tg or HI-Tg-specific Abs. 
Also, none ofthe mice produced Ab to OVA (data not shown) which was used as an 
antigen control. 
We subsequently tested the sera from younger (6-8 week old) mice to determine iflgG 
Ab to Tg and HI-Tg were present. Sera from young 6-8 week old male NOD.H2h4 mice 
were collected and tested for IgG Ab to Tg and HI-Tg (Figure 4.3). The results showed 
that there was very little Ab produced against Tg and HI-Tg compared to older 14-16 
week old mice (Figure 4.2- 4.3). However, the level oflgG Ab to Tg and HI-Tg was the 
same (Figure 4.3). These results suggested that there were no new determinants formed 
in Tg after the consumption ofNal water for 8 weeks in NOD.H2114 mice because an 
increase in iodination ofTg did not affect its antigenicity. As a control, we decided to 
test the IgG response to a panel ofTg peptides and their iodinated analogs. NOD.H2114 
sera from male mice on Nal water for 8 weeks were tested for the production of IgG to 10 
mouse Tg peptides and their iodinated analogs. The sera were pooled, 6 mice per group, 
and used at a final dilution of 1 :20. Only IgG Ab levels 2 SO above the average 
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background were considered detectable responses. Our data showed that sera from 
NOD.H2h4 mice on normal and Nal water for 8 weeks contained IgG against 6 of the 20 
Tg peptides (pll7, I-pl17, p304, I-p304, p2026,and I-p2617) (Figure 4.4 (A)). We chose 
to concentrate only on these 6 Tg peptides because IgG responses to the other Tg peptides 
tested were below or barely above the average background. Analysis ofthe IgG response 
against these 6 Tg peptides revealed that the ingestion of0.05% Nal water did not 
significantly enhance the IgG response to our panel ofTg peptides and their iodinated 
analogs. In fact, increased iodine intake did cause a significant decrease in the level of 
lgG against the Tg peptides p2026 and I-p2617 and it had no effect on the level oflgG 
against the Tg peptides p117, I-pll7, p304 and I-p304 (Figure 4.4 (A)). We also tested 
sera from young 6-8 week old NOD.H2114 mice to determine if there is spontaneous Ab 
reactivity to the 10 Tg peptides and their iodinated analogs (Figure 4.4 (B)) . We found 
that lgG responses were detected to 8 Tg peptides (p 117, I-p 117, p304, I-p304, 1-p 1931 , 
p2026, I-p2540, and I-p2617), but at lower levels compared to older (14-16 week old) 
mice (Figures 4.4 (A)). Taken together, these results suggest that there is spontaneous 
Ab reactivity to some of the Tg peptides tested in NOD.H2h4 mice and that these levels 
are not enhance by the consumption of dietary iodine. 
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Figure 4.2. NOD.H2114 IgG Ab response to Tg and HI-Tg. Sera were pooled from six 
male (A,C) and three female (B,D) NOD.H2h4mice after 8 weeks on 0.05% Nal water or 
normal water. A starting serum dilution of 1:100 was used to measure the IgG response 
to Tg (A, B) and HI-Tg (C, D). The optical density (O.D.) was measured at 405 nm after 
30 minutes. Responses to OVA were not detectable. Data are representative of two 
independent experiments. t-test analysis confinned: male response to Tg, p < 0.05 (Nal 
vs Control); male response to HI-Tg, p < 0.05 (Nal vs Control); female response to Tg, p 
< 0.05 (Nal vs Control); and female response to HI-Tg, p < 0.05 (Nal vs Control). 
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Figure 4.3. Serum lgG responses to Tg and ill-Tg from male, 6-8 week old 
NOD.H2h4 mice. Pooled sera from 6, 6-8 week old male NOD.H2h4 mice at a starting 
dilution of 1:100 were tested for the presence of IgG specific for Tg and HI-Tg. The O.D. 
was measured at 405 run after 30 minutes. 
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Figure 4.4. lgG response to Tg peptides and their iodinated analogs using male 
NOD.H2h4 mouse sera. Male, 12-14 week old (A) and naive 6-8 week old (B) 
NOD.H2h4 mouse sera were collected from mice on normal and 0.05% Nal water for 8 
weeks. The sera were pooled, 3 mice per group, and used at a 1:20 dilution. The O.D. 
was measured at 405 nm and read after 30 minutes. A response was deemed significant if 
it was 2 SD above the average background. The line in the figures represents the average 
background which ranges from 0.065 - 0.099 for the older mice and 0.066-0.077 for the 
younger mice. 
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4.3.3 T cell reactivity in lA-SA T in NOD.H2h4 mice 
To date, it has not been reported whether NOD.H2h4 mice can mount Tg-specific T cell 
responses during SAT. Since Tg incorporates and stores available hand HI-Tg has been 
shown to be more immunogenic in EAT than normal Tg (Dai et al., 2002), we wanted to 
determine ifT cells from NOD.H2h4 mice on Nal water for 8 weeks can recognize a panel 
of pathogenic Tg peptides and their iodinated analogs. We chose Tg peptides which were 
A k-binders because NOD.H2114 mice carry the A k gene, making them susceptible to lA-
SAT. Male and female NOD.H2114 mice were given 0.05% Nal water or normal water for 
8 weeks, starting at 6-8 weeks of age. After 8 weeks, mice were sacrificed and cells from 
spleens or thyroid-draining lymph nodes (TDLN) were collected and pooled (3 mice per 
group, male and female groups). T cell proliferation assays were conducted to measure 
the T cell reactivity against a panel of 18 Ak -binding, pathogenic Tg peptides and their 
iodinated analogs. A response was deemed significant if it was two SO above the 
background mean SI response. According to our findings, T cells from whole spleen or 
purified splenic CD4+ T cells (Figure 4.5) did not significantly respond to any of the Tg 
peptides tested or to Tg. Also, T cells from TDLN populations did not respond to the Tg 
peptides, Tg or HI-Tg (Figure 4.6). These data demonstrate that NOD.H2114 mice cannot 
mount Tg-specific T -cell responses to our panel of Tg peptides and their iodinated 
analogs during lA-SA T. 
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Figure 4.6. Responses of thyroid-draining lymph node cells to a panel of Tg 
peptides. (A) male and (B) female NOD.H2h4 mice were either given 0.05% Nal in their 
drinking water or normal water for 8 weeks, starting at 6-8 weeks of age. After 8 weeks, 
the mice were sacrificed and TDLN were removed, pooled (3 mice/group), and used in T 
cell proliferation assays. The cells were cultured in the presence or absence ofTg, HI-Tg, 
and a panel ofTg peptides for 4 days. During the last 18 hours of culture, 3[H]thymidine 
was added. At the end of culture the cells were harvested and measured for thymidine 
uptake as previously described in Fig. 4.7. A response was deemed significant if it was 2 
SD above the mean background SI value. 
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4.3.4. NOD.H2114 BM-DC cannot process HI-Tg or Tg to generate I-p117, I-p304, & 
I-p1931 
To determine if the lack of aT cell response to our panel ofTg peptides was due to a low 
frequency ofT cells present in the spleen and TDLN ofNOD.H2114 mice on 0.05% Nai 
water for 8 weeks, we decided to test T cell clones for reactivity to specific Tg peptides. 
We hypothesized that HI-Tg (43.2 I atoms/monomeric subunit), but not normal Tg (15-20 
I atoms/monomeric subunit), might be differentially processed and presented by 
NOD.H2114 BM-DCs to generate the cryptic pathogenic Tg peptides I-p117, I-p304, and 1-
p 1931 which will be recognized by A k -restricted Tg peptide-specific T cell clones. BM-
DC were generated from NOD.H2114 mouse bone marrow and cultured in the presence of 
10% GM-CSF for 10 days. On day 10, an activation assay was perfonned using BM-DC 
and three CD4+ T cell hybridoma clones specific for the Tg peptides 1-p 11 7, I-p304, and 
1-p 1931. These cells were cultured in the presence or absence ofTg, HI-Tg, specific Tg 
peptide, and control Tg peptide. Hybridoma activation was assessed by measuring the 
IL-2 content in culture supernatants using a proliferation assay of the IL-2 dependent 
CTLL cells. It was found (Figure 4.7) that none of the hybridomas were activated upon 
culture with Tg, HI-Tg or control peptide (p304). Only their specific ligand as a free 
peptide (l-pll7, I-p304, or I-p1931) could activate the hybridomas to secrete IL-2. These 
findings do not support the hypothesis that enhanced iodination ofTg facilitates the 
generation of these iodinated peptides during Tg processing in vitro. 
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Figure. 4.7. CD4+ T cell hybridomas specific for l-p117, I-p304, and I-p1931 are not 
activated by Tg or HI-Tg after processing by NOD.H2h4 BM-DC. The indicated T 
cell hybridoma clones (105 cells/well) were cultured with BM-DC (105 cells/well) in the 
presence or absence ofTg, HI-Tg, specific Tg peptide and control Tg peptide ( 1 ~-tM). A 
CTLL assay was performed as described in Materials and Methods to measure the IL-2 
secretion by each hybridoma. Positive control wells containing CTLL + supernatant with 
IL-2 had a cpm of 19682, and the negative control wells containing CTLL alone was 376. 
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4.4 DISCUSSION 
The ingestion of0.05% Nal water for 8 weeks caused severe IA-SAT in both male and 
female NOD.H2h4 mice confirming the earlier results of Braley-Mullen eta/. and Rasooly 
eta/. (Braley-Mullen eta/., 1999; Rasooly eta/. , 1996). However, we observed an 
increased incidence of SAT in female NOD.H2h4 mice given normal water for 8 weeks, 
leading to a similar incidence of SAT in female mice between the control and 
experimental groups. It is known that SAT incidence in NOD.H2h4 mice given normal 
water for 8 weeks is low (Rasooly eta/., 1996). The fact that 4/6 (67%) female mice 
given normal water for 8 weeks developed disease could be an indication that SAT may 
develop in our colony at a more accelerated rate than in other colonies. Braley-Mullen et 
a!. documented the kinetics ofSAT in NOD.H2h4 mice showing that mice on normal 
water for 8 weeks do not have mononuclear cell infiltration in their thyroid glands and 
that control mice rarely developed disease before the age of 6 months (Braley-Mullen, 
1999). The kinetics ofiA-SA Tin our colony should be examined to determine ifiA-SA T 
develops at a more rapid rate in our colony compared to other colonies. This may be the 
reason why we detect disease in female control NOD.H2114 mice. 
Sera were collected from all mice at the time of sacrifice to assay for the presence oflgG 
Ab to Tg and HI-Tg. We wanted to determine if an increase in dietary iodine influenced 
the antigenicity ofTg in IA-SAT. Our results suggested that both male and female 
NOD.H2h4 mice on Nal water for 8 weeks produced significant amounts of IgG Ab to Tg 
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compared to NOD.H2h4 mice on normal water for 8 weeks (Braley-Mullen eta/. , 1999; 
Rasooly et al., 1996). Also, both male and female NOD.H2h4 mice on Nal water for 8 
weeks produced significantly higher amounts of lgG Ab to HI-Tg compared to NOD.H2h4 
mice on normal water for 8 weeks. Further, we noticed that the level of IgG Ab against 
Tg was the same as the level oflgG Ab against HI-Tg for all groups of mice tested. 
These results were interesting because they did not provide evidence for the existence of 
iodine-modified epitopes being the target for autoantibodies in this model. Since it is 
known that excess iodine is incorporated and stored in the Tg molecule (Dunn, 1995), we 
assumed that the iodine consumed by NOD.H2h4 mice might be incorporated into Tg 
causing an increase in lA-SA T. If neodeterminants were generated at the B-celllevel 
then we would expect to see a higher Ab response to HI-Tg than Tg. The detection of 
low levels of IgG Ab in the serum of 6-8 week old NOD.H2h4 mice shows that there are 
existing IgG Ab to Tg and HI-Tg in the serum, however these levels are significantly 
lower than mice on Nal water for 8 weeks (p < 0.05). These results suggest that an 
increase in dietary iodine is causing an increase in the level of IgG Ab against Tg and HI-
Tg, but further experiments need to be conducted to determine what mechanisms are 
involved in this process and whether iodine is being incorporated directly into the Tg 
molecule. 
We decided to look at the IgG response to 10 Tg peptides and their iodinated analogs to 
determine if an increase in dietary h intake in NOD.H2h4 mice would prompt Ab 
production to these Tg peptides in the sera. We found that increased dietary intake of h 
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for 8 weeks did not enhance the IgG response to any of the Tg peptides tested when 
compared to the IgG response of control mice to these same Tg peptides. We did notice 
however, that the consumption of dietary 12 either decreased the antigenicity or had no 
affect on the antigenicity of these Tg peptides. Analyzing the non-iodinated analogs 
revealed that control mice produced antibody to the Tg peptides p 117, p304, and p2026, 
suggesting that there is "spontaneous" IgG production against these epitopes and that they 
are presumed to be on the molecular surface ofTg. In mice given Nal water for 8 weeks, 
we noticed relatively low and similar lgG responses to p304 and p 117 respectively, and 
that the lgG level to p2026 was significantly lower compared to the controls. If 12 
modifies Tg, there is no effect on the anti-p117 and anti-p304 responses because h atoms 
are not added at the vicinity of, or within these epitopes. Also, if h modifies Tg, there is a 
diminished response to p2026 because h atoms are added at the vicinity of, or within this 
epitope, therefore causing a blocking effect. If h does not modify Tg, it is hard to explain 
the selective decrease of the IgG response to p2026 only. In the case of the iodinated 
analogs, we observed that control mice had "spontaneous" IgG production against the Tg 
epitopes 1-p 117, I-p304, & l-p2617. For the Tg peptides 1-p 117 and l-p304, we can 
conclude that h atoms naturally occur at these sites and/or the addition of h to these sites 
does not alter their recognition by B cells, as it appears by comparison to the response 
against the non-iodinated analogs (see above). For the Tg peptide I-p2617, we can 
conclude that this site may be "naturally" iodinated and dominant in comparison to the 
other sites tested. This is further suggested by the lack of response to p2617 in control 
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mice. In NOD.H2h4 mice that were given Nal water for 8 weeks, we noticed that the IgG 
response to I-p 117 and I-p304 were low or similar to control mice. However, the IgG 
response to I-p2617 was significantly lower than in the controls. These results confirm the 
notion that the presence of h atoms within pl17 and p304 does not alter their antigenicity. 
However, the reduction of the IgG response to the Tg peptide I-p2617 in h-fed mice is 
more difficult to explain. If dietary h antigenically modifies Tg, it might be possible that 
iodination oftyrosyls close to the I-p2617 site might alter the immunodominance 
hierarchy, resulting in a decreased response. If dietary h does not antigenically modify 
Tg, it is hard to see why there is a selective IgG response to I-p2617, as was the case with 
the response to p2026 above. 
Due to a lack of published data on the T cell involvement in IA-SA Tin NOD.H2114 mice, 
we decided to study IA-SAT at the T cell level. Iodine is incorporated into the Tg 
molecule (Dunn, 1995), but we do not know ifTg iodination level influences 
development ofiA-SAT. We hypothesized that an increase in dietary h intake by 
NOD.H2h4 mice will modify the Tg molecule generating neodeterminants. However, we 
could not detect T cell responses to any of the 18 Tg peptides, Tg, or HI-Tg in both spleen 
and cervical draining lymph nodes. This lack of response may be due to a variety of 
factors: 1) there may be a low frequency ofTg peptide-specific T cells present in the 
spleen and TDLN, 2) Tg-peptide specific T cells may be present in these areas, however, 
we have not tested the proper Tg peptides, and 3) T cell priming could have occurred 
earlier than 8 weeks and therefore the T cells may have migrated to the thyroid. As 
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previously mentioned, mononuclear cell infiltration has been recorded as early as 2 weeks 
after the addition of0.05% Nal in the drinking water ofNOD.H2114 mice (Braley-Mullen 
et al., 1999). 
We tested three CD4+ T cell hybridomas specific for three iodinated Tg peptides. These 
cells were cultured in the presence ofNOD.H2114 BM-DC, which we used as APC. This 
experiment was conducted to ensure that the lack of detection of aT cell response in the 
spleen or lymph nodes was not due to a low frequency of effector T cells. Our results 
showed that none of the Tg peptides tested were generated after the processing ofHI-Tg 
or Tg by NOD.H2h4 BM-DC. From this experiment we can conclude that the processing 
ofHI-Tg in NOD.H2h4 APC does not generate the Tg peptides I-p117, I-p304, and I-
p1931. 
An increase in dietary lz intake did not enhance the Ab production to HI-Tg as compared 
to normal Tg or generate aT cell response to our panel ofTg peptides. This suggests that 
iodinated determinants in Tg may play a secondary role in the development of lA-SAT in 
NOD.H2114 mice. 
4.5 FUTURE DIRECTIONS 
An important factor which should be examined is the lz content ofT g. Does Tg from 
NOD.H2114 mice on 0.05% Nal water contain more h than Tg from NOD.H2114 mice on 
normal water? If it does, then h may affect the immunogenicity or antigenicity in Tg 
directly and therefore, HI-Tg may play a role in the development ofiA-SAT and SAT. 
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However, if it does not, then h may have another role in the development of lA-SA T, 
such as effects on Tregs· Iodine may down-regulate Tregs which are important in inhibiting 
effector T cells which cause disease. Recent literature has shown that B cell-deficient 
NOD.H2h4 mice without Tregs develop severe SAT compared to B cell-deficient 
NOD.H2h4 mice which had their Tregs still intact (Yu et al. , 2006). A second study 
confirmed that Tregs play a role in lA-SAT development because the depletion of 
CD4+CD25+ T cells through the injection of anti-CD25 monoclonal Ab caused lA-SAT in 
NOD.H2h4 mice (Nagayama, et af., 2007). 
Another area which should be tested is the reactivity of thyroid-infiltrating T cells from 
NOD.H2h4 mice given Nal water for 8 weeks. T cells which have migrated to the thyroid 
may show T cell responses to our panel ofTg peptides in contrast toT cells isolated from 
the LN and spleen. The fact that there was extensive mononuclear cell infiltration in the 
thyroid glands ofNOD.H2h4 mice after 8 weeks on Nal water shows that lA-SAT was 
induced and that there are mononuclear cells moving into the thyroid. Maybe the lack of 
a response to our panel ofTg peptides by T cells from the spleen and TDLN may be due 
to the Tg peptide-specific T cells migrating to the thyroid at a time point which is earlier 
than 8 weeks on Nal water. 
Lastly, due to the high numbers of female control mice developing lA-SA T in our 
experiment it is very important that we know exactly when IA-SA T develops in our 
colony. Braley-Mullen et af. have documented the kinetics of SAT in the NOD.H2h4 
mouse (Braley-Mullen et al., 1999), however, the kinetics of SAT in our colony may not 
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be the same as the kinetics in her colony and this needs to be determined. With these new 
kinetics data we can better interpret our results and better plan our experiments in order to 
ensure optimum lA-SA T development in our mice on Nal water and normal water. 
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